Welcome to the BXTAccelyon Newsletter

Thank you for signing up to receive information from BXTAccelyon. Our aim is to keep you informed on LDR brachytherapy and the treatment of prostate cancer via interesting and informative quarterly email newsletters.

 

LDR brachytherapy has been making headlines with high profile prostate cancer patients talking about their decision to have the treatment, and a worldwide study supporting LDR brachytherapy as the most effective treatment for long-term survival from the disease. Last month BXTAccelyon were proud to be the key sponsors of the UK and Ireland Brachytherapy Users Conference in Edinburgh, continuing the company’s commitment to LDR brachytherapy education.

‘Elvis’ Treated With LDR Brachytherapy

The inspiring story of Elvis impersonator Alan Moore made national headiness as he talked about how he was back on stage just two days after having LDR brachytherapy treatment for prostate cancer.

 
Read More

400th Patient Celebration

10 years after its first LDR brachytherapy patient was successfully treated for prostate cancer, an Australian hospital in Townsville celebrated treating its 400th patient.

 
Read More

Larger Waistline Increases Prostate Cancer Risk

A study has shown that men with larger waistlines could be at higher risk of developing aggressive prostate cancer

 
Read The Article

Wayne Sleep Talks About Prostate Cancer Diagnosis

Former Royal Ballet dancer Wayne Sleep, 67, has told how he opted for LDR brachytherapy after the shock of being diagnosed with prostate cancer following a routine operation.

 
Read More

Study Backs LDR Brachytherapy For Prostate Cancer Treatment

Seed or LDR brachytherapy has emerged as the most effective treatment for long-term survival according to the findings from an international study comparing prostate cancer outcomes. Read more

The Coach House, Grenville Court, Britwell Road, Burnham, SL1 8DF
0800 014 8060

Share on social

Share on FacebookShare on X (Twitter)

Vist our website  
This email was created with Wix.‌ Discover More